These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6784986)

  • 1. Marked increase in Ia-bearing macrophages during Trypanosoma cruzi infection.
    Behbehani K; Pan SC; Unanue ER
    Clin Immunol Immunopathol; 1981 May; 19(2):190-5. PubMed ID: 6784986
    [No Abstract]   [Full Text] [Related]  

  • 2. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
    La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC
    Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in cell-mediated immunity to Trypanosoma cruzi during experimental Chagas' disease.
    Maleckar JR; Kierszenbaum F
    Ann Trop Med Parasitol; 1983 Jun; 77(3):247-54. PubMed ID: 6226246
    [No Abstract]   [Full Text] [Related]  

  • 4. Mammalian Target of Rapamycin Inhibition in
    Rojas Márquez JD; Ana Y; Baigorrí RE; Stempin CC; Cerban FM
    Front Immunol; 2018; 9():313. PubMed ID: 29515594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi: aberrant expression of class II major histocompatibility complex molecules in skeletal and heart muscle cells of chronically infected mice.
    Meckert PC; Hontebeyrie-Joskowicz M; Chambo J; Levin M; Laguens RP
    Exp Parasitol; 1991 Jan; 72(1):8-14. PubMed ID: 1899648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(A)-containing RNA from the spleens of mice with Chagas' disease triggers in vitro macrophage resistance to Trypanosoma cruzi.
    Bertolini MC; De Lucca FL
    J Protozool; 1986 Feb; 33(1):81-4. PubMed ID: 2420985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of Trypanosoma cruzi to killing by macrophages.
    Kress Y; Bloom BR; Wittner M; Rowen A; Tanowitz H
    Nature; 1975 Oct; 257(5525):394-6. PubMed ID: 809716
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of silica on resistance to the "Brazil" strain of Trypanosoma cruzi in C57 BL/10 (B10) mice.
    Tanowitz HB; Rager-Zisman B; Wittner M
    Trans R Soc Trop Med Hyg; 1980; 74(6):820-2. PubMed ID: 6259784
    [No Abstract]   [Full Text] [Related]  

  • 10. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi.
    Kierszenbaum F; Knecht E; Budzko DB; Pizzimenti MC
    J Immunol; 1974 May; 112(5):1839-44. PubMed ID: 4361979
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo and in vitro interaction of Trypanosoma cruzi with mouse macrophages and heart muscle cells--film presentation.
    Ax W; Dyonysius J; Hungerer KD
    Adv Exp Med Biol; 1979; 114():673-6. PubMed ID: 111486
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Volpini X; Ambrosio LF; Fozzatti L; Insfran C; Stempin CC; Cervi L; Motran CC
    Front Immunol; 2018; 9():859. PubMed ID: 29743880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high throughput analysis of cytokines and chemokines expression during the course of Trypanosoma cruzi experimental oral infection.
    Rodrigues AA; Notário AF; Teixeira TL; e Silva RT; Quintal AP; Alves RN; Brígido PC; Siqueira CS; Martins FA; Machado FC; Clemente TM; da Silva AA; Borges BC; Teixeira SC; dos Santos MA; da Silva CV
    Acta Trop; 2016 May; 157():42-53. PubMed ID: 26827742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to Trypanosoma cruzi.
    Brener Z
    Adv Parasitol; 1980; 18():247-92. PubMed ID: 6159781
    [No Abstract]   [Full Text] [Related]  

  • 16. BCG-induced resistance in Trypanosoma cruzi experimental infections.
    Bertelli MS; Alcantara A; Brener Z
    Tropenmed Parasitol; 1981 Jun; 32(2):93-6. PubMed ID: 6789512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of the mechanisms of resistance against experimental Trypanosoma cruzi infection. I: Role of the macrophages in resistant and suceptible strains of mice.
    Pécora IL; Barcinski MA
    Rev Bras Biol; 1979 May; 39(2):445-50. PubMed ID: 119283
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages.
    Bergeron M; Blanchette J; Rouleau P; Olivier M
    Parasite Immunol; 2008 May; 30(5):280-92. PubMed ID: 18312504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denervation and the immune response in mice infected with Trypanosoma cruzi.
    Ribeiro dos Santos ; Hudson L
    Clin Exp Immunol; 1981 May; 44(2):349-54. PubMed ID: 6796312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
    Buckner FS; Wipke BT; Van Voorhis WC
    Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.